Two formulations of hydrated sodium calcium aluminosilicate (HSCAS-1 and HSCAS-3), anticaking agents for mixed feed, were added to the diets of growing barrows and were evaluated for their potential to diminish the clinical signs of aflatoxicosis. The experimental design consisted of 8 barrows (2 replicates of 4 each/treatment) assigned to 1 of the following 6 treatment diets (total of 48): 1) 0 g of HSCAS-1 or HSCAS-3 and 0 mg of aflatoxin (AF)/kg of feed (control); 2) 5 g HSCAS-l/kg of feed; 3) 5 g HSCAS-3/kg of feed; 4) 3 mg AF/kg of feed; 5) 3 mg AF plus 5 g HSCAS-l/kg of feed; or 6) 3 mg AF plus 5 g HSCAS-3/kg of feed. Barrows were maintained in indoor concrete-floored pens, with feed and water -available for 28 days (from 8 to 12 weeks of age). Barrows were observed twice daily and weighed weekly, and blood samples were collected at day 28 for hematologic, immunologic, and serum biochemical measurements. At the termination of the study, barrows were euthanized and necropsied. Barrow body weight gains were diminished, compared to those of controls, by consumption of AF alone and both of the AF plus HSCAS diets; however, the AF plus HSCAS-1 and AF plus HSCAS-3 barrow body weight gains were significantly greater (P < 0.05) than those of the AFalone barrows, No toxic responses or performance differences were noticed for barrows consuming either of the HSCAS-alone diets. Serum concentrations of alkaline phosphatase, gamma glutamyltransferase, calcium, cholesterol, albumin, triglycerides, and urea nitrogen were altered in barrows of the AF-alone treatment. The use of HSCAS prevented most but not all of the AF-induced changes in biochemical values. Immunologic measurements that were adversely affected by AF included mitogen-induced lymphoblastogenesis and peritoneal macrophage activity and function. The addition of HSCAS to AF-contaminated diets protected barrows from some of these toxic changes. Although immunologic measurements in the AF plus HSCAS groups were significantly different than those of the AF-alone group, values were still not equivalent to those of controls. These findings suggest that HSCAS-1 and HSCAS-3 are equal in their ability to protect against the toxicity of AF. Although these compounds may offer a novel approach to the preventive management of aflatoxicosis in livestock and poultry, HSCAS is not approved by the US Food and Drug Administration for treatment of animal diets for prevention of mycotoxicosis.
Aflatoxins (a structurally similar group of polysub-added to animal diets, have promise in their ability to stituted coumarins) are secondary fungal metabolites prevent signs of certain mycotoxicoses. Dietary addiproduced by the Aspergillus flavus-parasiticus group. Swine are highly sensitive to the effects of aflatoxin tions of zeolite, 27 bentonite, 1 or spent bleaching clay from canola oil refining 28 have been reported to di-(AF), and the toxic effects of AF in swine have been minish the adverse effects of T-2 toxin and zearalenone well documented. 5, 16, 26 Swine production methods (i.e., in rats. Clay and zeolitic minerals encompass a conconfinement rearing on high-density diets) increase the siderably complex and diverse family of aluminosiliprobability that pigs will be exposed to the effects of cates that possess a variety of functional properties. AF-contaminated feed. Therefore, practical and cost-Some aluminosilicates can bind AF in vitro, and I effective methods to detoxify AF-containing feedstuffs compound in particular, hydrated sodium calcium aluare in great demand. Specific aluminosilicates, when minosilicate (HSCAS), forms a highly stable complex with AF. 24 At 0.5% of the diet, HSCAS has protected From the US Department of Agriculture, Agricultural Research poultry, [18] [19] [20] [21] 24 swine, 3, 13 and lambs 14 by 55-l00% from Service, Food Animal Protection Research Laboratory, Route 5, Box the deleterious effects of AF. At 1.0% of the diet, HSCAS pound has shown greater in vitro binding to AF than the original HSCAS product (Phillips TD, unpublished data). In a series of 3 broiler studies, the modified HSCAS protected broiler chicks by 88% against the toxic effects of AF. 20 Because HSCAS can prevent clinical aflatoxicosis in various species and because the second-generation HSCAS shows greater in vitro binding capacity for AF and in vivo protection of broiler chicks, 20 the objective of this study was to compare the ability of the original HSCAS and a chemically modified HSCAS to interact with AF in growing barrows.
Materials and methods
Pigs and diets. Forty-eight 8-wk-old crossbred (Yorkshire x American Landrace x Hampshire) weaned barrows (mean body weight = 14.2 kg) were identified by individual ear tags and tattoos, assigned by weight to treatment groups, housed in concrete-floored indoor pens, and provided a starter diet and water ad libitum. Corn/soybean meal/whey starter diets (22% protein) either met or exceeded recommended critical nutrient concentrations. 23 After acclimation, 8 barrows (2 replicates of 4 barrows each) were assigned to 1 of 6 treatment groups (a total of 48 barrows): 1) 0 g of HSCAS-1 a or HSCAS-3 b and 0 mg of AF/kg of feed (control); 2) 5 g HSCAS-1/kg of feed; 3) 5 g HSCAS-3/kg of feed; 4) 3 mg AF/kg of feed; 5) 3 mg AF plus 5 g HSCAS-1/kg of feed; or 6) 3 mg AF plus 5 g HSCAS-3/kg of feed. Barrows were fed for 28 days. Aflatoxin was produced on rice powder by described methods 13, 18, 19 and was incorporated into diets to achieve the desired concentration of 3 mg total AF/kg of feed. The rice powder was analyzed for AF content and was determined by high pressure liquid chromatography to consist of 79% AFB 1 , 16% AFG 1 , 4% AFB 2 , and 1% AFG 2 . l7 The rice powder was added to diets not to exceed 1% of the basal diet. The treatment diet containing AF alone was analyzed, and the presence of parent AF was confirmed by gas chromatography/ quadrupole mass spectrometry. 2 Measurements. Barrows were observed twice daily and weighed once weekly. Feed consumption was recorded once weekly. On days 1 and 14, peritoneal macrophages were sensitized to a foreign antigen by injecting barrows intraperitoneally with 0.5 ml of chicken red blood cells (RBC) (40% [v/v] suspension, washed in Alsevor's solution). Blood samples for hematologic, immunologic, and serum biochemical measurements were obtained from each barrow on day 28 by vena puncture via the anterior vena cava. Hematologic measurements for prothrombin and activated partial thromboplastin times were made by use of an automated coagulation instrument according to the manufacturer instructions c30 and measurements for RBC, mean cell volume, hematocrit, hemoglobin, and leukocytes (WBC) were made by use of a Coulter counter d as previously described.' Mean cell hemoglobin and mean cell hemoglobin concentration were calculated. Serum values were determined using an autoanalyzer e by described methods 7, 12 and included aspartate aminotransferase, alkaline phophatase (ALP), cholinesterase, and gamma glutamyltransferase (GGT) activities and albumin, cholesterol, creatinine, glucose, inorganic phosphorus, total protein, triglycerides, and urea nitrogen concentrations.
Immunologic measurements. Blood lymphocytes were collected on day 28, and the in vitro mitogen-induced lymphoblastogenesis stimulation index (uptake of 3 [H]thymidine) was utilized to evaluate cell-mediated immune response to the treatment diets .6,14,22 Blastogenic response to phytohemagglutinin (PHA) f was measured utilizing procedures previously reported. 6, 14, 22 The stimulation index for each blood sample was calculated as counts in PHA-stimulated cells minus counts in unstimulated cells divided by counts in unstimulated cells.
At necropsy on days 29 and 30, a peritoneal lavage on all barrows was performed by aseptic technique with 500 ml of sterile physiological saline solution. A minimum of 60 ml of lavage solution was collected from each pig and centrifuged, and macrophages were recovered. The cells were washed twice with Isocove's modified Dulbecco's plus tissue culture medium (IMDM), counted, and analyzed for viability (trypan blue exclusion). One milliliter of IMDM containing 2 x 10 5 live peritoneal cells was plated in each chamber of a double-chambered, tissue culture chamber slide and incubated for 24 hr in a 5% CO, humidified atmosphere at 37 C. The chambers were washed 3 times with 2 ml of IMDM each time. One milliliter of IMDM containing 2 x 10 6 washed chicken RBC was added to each chamber and incubated as described above for 2 hr. Each chamber was again washed 3 times with 2 ml of IMDM each time. The cells were fixed by the addition of 2 ml of acetone to each chamber, stained with hematoxylin on an automated slide stainer, g and examined with a light microscope for the presence of phagocytic activity and quantity of RBC phagocytized.
Necropsy. On days 29 and 30, all barrows were euthanized h and examined. Liver was weighed and organ weight was calculated as a percentage of body weight (g/100 g). Specimens of liver from 6 barrows/treatment were fixed in neutral buffered 10% formalin solution, embedded in paraffin, sectioned at 5 µm, stained with hematoxylin and eosin, and examined microscopically.
Statistical evaluation. Data were grouped and expressed as mean ± SEM. Group means for body weight, organ weight, and hematologic, immunologic, and serum biochemical measurements were subjected to an analysis of variance 29 using the general linear model procedure and a software package. 25 Significant differences determined by the ANOVA for treatment groups were compared, using Duncan's multiple-range procedure. 4 All statements of significance were based on P < 0.05.
Results
As compared with controls, final body weight was reduced in the AF and AF plus HSCAS-1 barrows, and body weight gain was reduced in all of the AF barrows; however, although both the AF plus HSCAS barrows had statistically lower body weight values than those of controls, the body weights of the AF-alone barrows were less than those of the AF plus HSCAS barrows (Table 1) . Feed efficiency was not affected on the basis of treatment, although feed consumption was decreased in the AF-alone group (data not shown).
Serum activities of ALP and GGT were increased Table 3 . Mean (± SEM)* immunologic responses of growing bargrowing pigs fed aflatoxin (AF)-contaminated diets and 2 types of rows fed aflatoxin (AF)-contaminated diets and 2 types of hydrated hydrated sodium calcium aluminosilicate (HSCAS) for 28 days. sodium calcium aluminosilicate (HSCAS) for 28 days.
in the pigs of the AF-alone treatment, ALP was elevated in the AF plus HSCAS-3 pigs, and triglycerides were increased in both of the AF plus HSCAS groups ( Table 2) . Serum values of calcium, cholesterol, and albumin were decreased in the AF-alone group, and urea nitrogen was decreased in the AF-alone group and in both of the AF plus HSCAS groups. HSCAS-1 and HSCAS-3 spared the AF-induced changes in cholesterol, albumin, and GGT, whereas only HSCAS-1 had any effect on AF-altered values of ALP. Serum values of aspartate aminotransferase, cholinesterase, creatinine, total protein, glucose, or inorganic phosphorus were not affected on the basis of treatment (data not shown). There were no hematologic differences for RBC, mean cell volume, hematocrit, WBC, hemoglobin, prothrombin time, activated partial thromboplastin time, mean cell hemoglobin, or mean cell hemoglobin concentration values related to treatments (data not shown).
lymphoblastogenesis was likewise higher in the AF plus HSCAS-1 pigs than in the AF-alone pigs. AF-induced reduction in macrophage activity and function was ameliorated by the presence of either HSCAS compound, although these values were still less than control values. Both HSCAS compounds protected equally against AF-induced alterations in phagocytic function.
Lymphoblastogenic responses to PHA were decreased in the AF, AF plus HSCAS-1, and AF plus HSCAS-3 pigs as compared with controls (Table 3) . However, the HSCAS-3 stimulation index, although less than the control value, was greater than the AF or AF plus HSCAS-1 values. The stimulation index for At necropsy, livers from the AF-alone pigs were pale, rubbery, and tan, whereas livers from AF plus HSCAS-1 or AF plus HSCAS-3 pigs were darker and less resistant to cutting. Liver relative weight was greater in AF, AF plus HSCAS-1 or AF plus HSCAS-3 pigs than in controls ( Fig. 1) , indicating no effect of either HSCAS formulation on AF toxicity as measured. Microscopically, lesions were not observed in livers of the control, HSCAS-1, or HSCAS-3 barrows. In the AF-alone group, 5 of the 6 livers examined had moderate to severe diffuse hepatocellular lipidosis accompanied by bile duct hyperplasia. Mild diffuse lipidosis was observed in hepatic tissue of the sixth barrow. Differences could not be detected between histopathologic lesions of the AF plus HSCAS-1 and the AF plus HSCAS-3 tissues. The lesions present in liver sections from these two groups were similar in severity and distribution binding by HSCAS.
Barrows of the AF treatment group had alterations in serum values of ALP, GGT, calcium, cholesterol, triglycerides, albumin, and urea nitrogen. These serum biochemical changes are consistent with the effects induced by AF in growing swine. [8] [9] [10] [11] 13 Although the use of HSCAS-1 or HSCAS-3 in the present study diminished the effects of AF, some variabilities were noted, and levels of protection were not 100%. Previous studies have indicated that HSCAS-1 added to AF-contaminated diets would prevent altered serum biochemical values in swine, 13 poultry , 18-21 and lambs. 14 Likewise, although liver weight and hepatic lesions have been shown to increase during aflatoxicosis, the use of HSCAS-1 in AF-containing diets produced normal hepatic weight, gross appearance, and histology in growand consisted of mild periportal hepatocellular dosis. Bile duct hyperplasia was not observed.
lipi-
The similarity of the mild lesions prevented distinguishing 1 group from the other. However, differences in severity of lesions from the AF-alone and the 2 AF plus HSCAS groups were quite distinct.
Discussion
Underperformance induced by AF treatments in barrows of this study was similar to results reported for swine given similar dosages of AF in the feed. 3, 8, 11, 13 The addition of HSCAS-1 to AF-contaminated diets is reported to decrease the toxicity of AF by 55-100% for weight gain and growth in poultry, [18] [19] [20] [21] 24 swine, 3, 13 and lambs. 14 In the present study, the weight gain of the AF-alone pigs was 44% less than that of controls, the AF plus HSCAS-1 pigs weight gain was 15% less than that of controls, and the AF plus HSCAS-3 pigs weight gain was 14% less than that of controls. The use of HSCAS-1 or HSCAS-3 at 0.5% of the diet in this study protected barrows from diminished weight gain by 65% and 69%, respectively, but did not achieve the 100% protection conferred to barrows by 0.5% or 2.0% HSCAS-1 in a previous study. 13 The reasons for these differences are unclear but may be related to biological variation in test animals, dietary composition, or interference with binding by unknown factors. Variations in weight gain protection (55-90%) by HSCAS-1 in poultry do occur from study to study. [18] [19] [20] [21] 24 However, 1 major difference in the 2 swine studies was the dietary protein content and source. The present study utilized 22% protein starter diets for-ing barrows. 13 Although some differences in appearance were evident among treatment liver gross groups in the present study, substantial but not complete prevention of AF-induced hepatosis was effected by HSCAS-1 or HSCAS-3 (as evidenced by histopathologic evaluation).
Immunosuppression is a well-recognized sequel of AF toxicosis, 5, 16, 26 and the results of the present study support that observation. Macrophage activity and function in this study were reduced and cell-mediated immune function was hampered by the presence of AF, with or without HSCAS compounds in diets. The addition of HSCAS-1 and HSCAS-3 enhanced the ability of macrophages to respond to foreign RBCs when compared with phagocytizing activity of macrophages of the AF-alone pigs. However, macrophage activity and function of the AF plus HSCAS-1 or AF plus HSCAS-3 pigs was still reduced as compared with control values. Stimulation indices for AF plus HSCAS-1 or AF plus HSCAS-3 were higher than those of the AF-alone group but were not equivalent to control values. The HSCAS compounds afforded some protection against the immunotoxic effects of AF, but total protection was not achieved. In a study of growing lambs, the presence of HSCAS-1 in AF-contaminated diets prevented the AF-induced decrease of lymphoblastogenic responses to PHA, and values were not different than those of controls. 14 The clinical findings, clinicopathologic data, and microscopic hepatic lesions suggest that a diet of 3 mg AF/kg of feed induced aflatoxicosis in growing barrows. The dietary inclusion of 0.5% of HSCAS-1 or HSCAS-3 alone does not adversely affect performance, they substantially reduce the toxic expression of AF when added to AF-contaminated diets, and these compounds can protect against 65-6 9% of the growth in-hibitory effects of AF in swine. Although in vitro data and in vivo protection in chicks 20 suggest that HSCAS-3 is superior to HSCAS-1 for binding to AF, the present 11. study indicates that these 2 compounds are equal in their in vivo protection against AF in swine. Although 12. these compounds may offer a novel approach to the preventive management of aflatoxicosis in livestock and poultry, these HSCAS compounds are not ap-13. proved by the US Food and Drug Administration for treatment of animal diets for icoses.
prevention of mycotox- 19. Mention of a trade name, proprietary product, or specific equipment does not constitute a guarantee or warranty by the US Department of Agriculture and does not imply its approval to the exclusion of other products that may be suitable. 20.
